Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1993-07-07
2000-07-11
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241931, 42419611, 4242151, 530324, 530325, 530326, 530327, 530328, 530350, 530402, 530403, A61K 3915, A61K 3804, A61K 3808, A61K 3810
Patent
active
060868805
ABSTRACT:
A number of subunits of various rotaviral proteins have been shown to be useful in diagnosis, therapy, and prevention of rotaviral infection. Specifically, the subunits represented by positions 40-60 of VP6, 232-255 and 240-248 of VP4, and 247-259 and 275-295 of VP7 are thus useful. Furthermore, the VP4 subunits have therapeutic value in competing with the native viral protein in an essential step in infection.
REFERENCES:
patent: 4190645 (1980-02-01), Almeida
patent: 4474757 (1984-10-01), Arnon et al.
patent: 4591552 (1986-05-01), Neurath
patent: 4629783 (1986-12-01), Cosand
patent: 4704275 (1987-11-01), Wyatt et al.
patent: 4737487 (1988-04-01), Watts et al.
patent: 5071651 (1991-12-01), Sabara et al.
Redmond et al., (1991) Molecular Immunology 28(3):269-278.
Frenchick et al., in Applied Virology Research, 1988, vol. 1, Edited by Edouard Kurstak et al., (Plenum Publishing Corporation), pp. 141-151.
Ijaz et al., (1991) Journal of Virology 65(6):3106-3113.
Sabara et al., J. Virol. (1985) 53(1):58-66.
Estes et al., Microbiol. Rev. (1989) 53:410-449.
Gunn et al., J. Virol. (1985) 54(3):791-797.
Estes et al., Nucleic Acids Res. (1984) 12(4):1875-1887.
Woode et al., Viral Immunol. (1989) 2(2):127-132.
Gouvea et al., J. Gen. Virol. (1986) 67:577-581.
Estes et al. Immunol. Invest. (1989) 18:571-581.
Gilbert et al., Virus Res. (1987) 7:49-67.
Greenberg et al., J. Gen. Virol. (1983) 64:313-320.
Greenberg et al., J. Virol. (1983) 47(2):267-275.
Lazdins et al., J. Virol. (1985) 56(1):317-319.
Glass et al., Virology (1985) 141:292-298.
Brown et al., Bio/Technology (1985) 3:445-448.
Bittle et al., Nature (1982) 298:30-33.
Emini et al., Nature (1983) 304:699-703.
Richardson et al., J. Virol. (1994) 51(3):860-862.
Lopez et al., Virology (1985) 144:11-19.
Clark et al., J. Virology (1981) 39(3):816-822.
Sabara et al., J. Virol. (1985) 56(3):1037-1040.
Cruse et al.; Illustrated Dictionary of Immunology, CRC Press, 1995.
Woode et al., Viral Immunology, vol. 2, No. 2, pp. 127-132 (1989).
Goodman, Basic & Clinical Immunology, Fudenberg et al. (ed.), Lange Medical Publications, Los Altos, California, pp. 32-40 (1976).
Rudinger, Peptide Hormones, Parson (Ed.) U Park Press, Baltimore, pp. 1-7 (1976).
Cram et al., Organic Chemistry, 2.sup.nd Edition, McGraw-Hill Book Company, New York, pp. 607-613 (1964).
Frenchick Patrick John
Gilchrist James Elton
Ijaz Mohammad Khalid
Potter Andrew Allan
Redmond Mark J.
Budens Robert D.
The University of Saskatchewan
LandOfFree
Rotavirus peptide compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rotavirus peptide compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rotavirus peptide compositions and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-539258